Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2026-03-01 @ 4:46 PM
Study NCT ID:
NCT03724968
Status:
TERMINATED
Last Update Posted:
2021-04-20
First Post:
2018-10-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nivolumab Plus Relatlimab or Ipilimumab in Metastatic Melanoma Stratified by MHC-II Expression
Sponsor:
Organization: